person
Romain G.
- Country
- France
- Department
- Hematology
Research Overview
assignment
19
Clinical Trials ·
- Efficacy of Venetoclax Plus Cytarabine Versus Idarubicin Plus Cytarabine in Post-Remission Therapy for Elderly Patients with Acute Myeloid Leukemia
- Phase 1b/2 Study of MK-1045 Monotherapy and MK-1045 Plus Tocilizumab in Adults with Relapsed/Refractory Non‑Hodgkin Lymphoma
- An ALFA 2101 multicenter randomized phase II study: CPX-351 versus intensive chemotherapy in patients with de novo intermediate or adverse risk AML stratified by genomics
location_city
13
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
234
Sites with multiple studies
Has run more than one trial at 234 of 436 partner sites.
Specializations
Lymphoid Malignancies
Specializes in treating chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), with particular focus on novel therapeutic approaches using targeted agents and combination therapies.
- BTK inhibitor therapy optimization
- Fixed-duration treatment strategies
- MRD-guided treatment approaches
Aggressive Lymphomas
Conducts research in diffuse large B-cell lymphoma (DLBCL) and Richter's syndrome, investigating innovative treatment combinations and immunotherapy approaches.
- First-line therapy optimization
- Bispecific antibody treatments
- Immunochemotherapy combinations
Indolent Lymphomas
Investigates treatment strategies for follicular lymphoma, focusing on both newly diagnosed and relapsed/refractory disease settings.
- Novel agent combinations
- Targeted epigenetic therapy
- Immunomodulatory approaches
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.